Extracranial Vertebral Artery Dissection Presenting as Subarachnoid Hemorrhage

To the Editor
We were interested by the recent case report by Kaplan et al 1 of extracranial (C3 to C7) vertebral artery dissection with subarachnoid hemorrhage (SAH). The patient was said to be "the first patient with an extracranial vertebra] artery pseudoaneurysm presenting with subarachnoid hemorrhage . . . . " We are surprised that the authors did not discuss the possibility of an associated intracranial vertebral artery dissection.
Subarachnoid hemorrhage is present in more than half of the reported cases of intracranial vertebral artery dissection, 2 which account for nearly 5% of lethal SAH. 3 Furthermore, 20% of vertebral artery dissections involve both the extracranial and intracranial portions. 4 In the case report by Kaplan et al, angiography was performed twice and said to be normal, but no specific information was provided on the intraCTanial circulation. Moreover, a normal angiogram would not rule out an intracranial vertebral artery dissection, 3 which is notoriously difficult to diagnose, particularly in the presence of SAH.
We reported in this journal 6 a case very similar to that of Kaplan et al, involving a 44-year-old woman who presented with SAH and blood in the third ventricle. Cerebral angiography disclosed a diffuse but moderate narrowing of the intracranial segment of the right vertebral artery and an aneurysm in its extracranial segment at the Cl level. The patient recovered completely without treatment, and control angiography performed 6 weeks later was normal. The interesting fact is that the diagnosis of intracranial dissection of the vertebral artery would have been impossible without the coexistence of the typical image of a dissected aneurysm on the extracranial segment.
We would therefore like to suggest that the most likely explanation for the occurrence of SAH in the case of Kaplan et al was, as in ours, an associated intracranial vertebral artery dissection.
We were also rather surprised by the therapeutic approach of this case. Admittedly, the proper management of vertebral artery dissection is still controversial. However, it is well established (from a number of recent series of vertebral artery dissections, 4711 which Kaplan et al do not refer to in their very surgically oriented review of the literature) that the prognosis of extracranial vertebral artery dissection is usually good and that in the vast majority of patients with stenosis the artery returns to normal in less than 3 months. 4 *- 12 The authors performed a balloon occlusion of the vertebral artery to "reduce the threat of hemorrhage from the pseudoaneurysm." Rebleeds occur in 30% of patients with intracranial vertebral artery dissections initially presenting with SAH, 1214 but there is no evidence that extracranial dissecting aneurysms carry a risk of rebleeding. The natural history of such aneurysms, which is much better known for the carotid artery, is that they resolve or improve in almost 50% of cases, and when they persist, they don't rupture. 
Letters to the Editor Could Transient Ischemic Attacks Have a Cerebroprotective Role?
To the Editor I would like to offer for reflection a hypothesis that is bound to be controversial, namely, that under some circumstances a transient ischemic attack (TIA) may trigger cerebroprotective events that may increase the brain's resistance to subsequent infarction. This hypothesis arises largely from animal experiments but may have some support from patient data. It is not the purpose of this letter to change the current therapeutic approach to TTAs but rather to point out that a more complete understanding of the TIA process and its implications may be possible.
Some investigators have shown that brief ischemic insults can under some circumstances increase the brain's tolerance to a subsequent "significant" episode of ischemia. Kirino and his colleagues, 1 using bilateral common carotid artery occlusion in the gerbil, showed that a 5-minute ischemic episode causes significant injury to the CA1 region of hippocampus. However, neuronal damage was reduced when the same 5-minute ischemic insult was preceded 1 to 4 days earlier by a 2-minute episode of ischemia. This protection was removed if the two ischemic episodes were spaced more closely. These data agree with the findings of Kitagawa et al 2 and Kato et al, 3 who showed that both the duration of the first ischemic insult and the interval between the two episodes are important determinants of the degree of protection. It is reasonable, then, to conclude that at least in animal experiments, transient episodes of ischemia that do not cause damage may under some circumstances be neuroprotective. These data suggest that short-lasting ischemic episodes probably upregulate enzymatic and other protein synthetic activities that can ultimately confer protection.
It is now clear that in response to short-lasting stimuli at its surface the cell can activate genes that may lead to alterations in its protein composition. 4 We have shown in animal studies in vivo that transient ischemia such as occurs during a TIA can reversibry activate voltage-sensitive calcium channels (VSCC). 3 In vitro experiments have established that calcium influx through VSCCs can lead to rapid transcriptional activation of immediate early genes (IEGs), a class of genes involved in signal transduction to the nucleus. 6^ Other stimuli, such as activation of the N-methyl-Daspartate receptor, can also elicit IEG expression. Once induced, IEG mRNAs are shuttled to the cytoplasm and translated into proteins, eg, FOS or JUN. These proteins reenter the nucleus, bind to their target genes, and regulate their transcription. 8 Distinctive compensatory changes in neuronal gene expression appear to be mediated by the specific IEGs induced. A large number of these have now been identified, and a significant effort is now aimed at describing the specific IEGs induced over time in different ischemic models, with the goal of distinguishing EEGs that may lead to protection from those that may signal or induce cell death.
An and colleagues, 9 by using a model of transient reversible focal ischemia, recently showed that;Wi B and c-fos mRNAs were induced by ischemia, and their relative concentrations were significantly higher at 60 minutes of reperfusion. The authors showed that the increase in IEG expression was associated with a fourfold to sixfold increase in the activity of the transcription factor AP-1, which may in turn induce the expression of late response genes such as those that lead to the production of gTOwth factors. While it is clear that some IEGs may modify the postischemic cerebral environment in potentially protective ways, Smeyne and colleagues 10 showed in nonischemic models that c-fos will appear just before histological evidence of cell death. Using transient global ischemia in which a period of four-vessel occlusion is subsequently followed by selective vulnerability of striatal and CA1 neurons, 11 Wessel and colleagues 12 showed that the CA1 region developed an early and late c-fos signal after ischemia. It should soon be possible to experimentally modify the regional concentrations of one or more of these mRNAs to test for the protective or destructive effect that each may mediate.
Heat-shock protein (HSP) is also likely to play a role in neuronal protection from ischemia. Since HSP mRNA does not contain an AP-1 site, its regulation is probably distinct from that of IEGs. Induction of HSP was shown to be protective in retinal cells. 13 Using cell culture studies Lowenstein et al 14 suggested that stress proteins may have a protective role in excitotoxicity. Kirino and his colleagues 1 were able to induce tolerance to ischemia in the gerbil hippocampus and correlated it with the induction of HSP. This protein is known to rise regionally after ischemia 15 and may thus possess neuroprotective properties that can be experimentally modified.
It is clear, then, that a brain region that has been exposed to an episode of transient ischemia can rapidly set in motion mechanisms that may lead to long-term alterations in its structural and functional protein composition. At least some of these changes may be neuroprotective, and others may carry cell death programs. The experimental challenge is to identify these factors and test the effect of modifying them on cell survival.
At the clinical level, the occurrence of a TIA identifies the patient as being at increased risk of developing a stroke, but TIAs have never been studied from the perspective that they may increase the brain's resistance to subsequent ischemic events. Patients who have a single TIA face a smaller (and a declining) risk of serious vascular events than those who have recurrent ones.
16
-18 These data call for further analysis to see if, akin to the animal experiments, the interval between the TIAs is an important parameter, but it is possible that in a subgroup of patients a single TIA may set up conditions for a higher cerebral threshold for subsequent ischemic events. The earliest demographic studies have also shown that the incidence of stroke after untreated TIAs declines over time 19 despite the persistence of the risk factors and the absence of medical or surgical therapy. This may also reflect the brain's enhanced ability after a TIA to withstand further insults without producing symptoms. Despite these observations,
